SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

Sahil Parikh, MD, director of endovascular services at Columbia University Irving Medical Center, said treating these patients can be quite challenging. 

American Heart Association President Michelle Albert, MD, talked to us about about how to address health inequities in cardiology departments.

More than 500 clinical AI algorithms have now been cleared by the FDA, with the majority just in the past couple years.

MGMA and AHA discuss how the end of the PHE will impact healthcare stakeholders.

The American Medical Association said its members are "extremely disappointed and dismayed" that Congress did not act in time. The Medical Group Management Association shared a similar message. 

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association, include staving off the large Medicare reimbursement cuts, continuation of telehealth reimbursements, and revamping prior authorizations. 

The American Medical Association is asking Congress to step in before new Medicare payment cuts go into effect in 2023.